SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-028215
Filing Date
2023-08-08
Accepted
2023-08-08 16:21:57
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20230630.htm   iXBRL 10-Q 1363444
2 EX-10.1 lyel-20230630x10qxexx101.htm EX-10.1 72874
3 EX-31.1 lyel-20230630x10qxexx311.htm EX-31.1 10649
4 EX-31.2 lyel-20230630x10qxexx312.htm EX-31.2 10619
5 EX-32.1 lyel-20230630x10qxexx321.htm EX-32.1 7494
11 image_0b.jpg GRAPHIC 41412
12 lseelysignaturea.jpg GRAPHIC 2663
13 lyel-20230630_g1.jpg GRAPHIC 141479
  Complete submission text file 0001628280-23-028215.txt   7201258

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20230630.xsd EX-101.SCH 46194
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20230630_cal.xml EX-101.CAL 62281
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20230630_def.xml EX-101.DEF 245653
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20230630_lab.xml EX-101.LAB 654249
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20230630_pre.xml EX-101.PRE 439053
62 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20230630_htm.xml XML 818296
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 231151734
SIC: 2834 Pharmaceutical Preparations